Prognostic importance of renal function 1 year after heart transplantation for all-cause and cardiac mortality and development of allograft vasculopathy

Transplantation

Volumn 84, Issue 2, 2007, Pages 149-154

  Arora, Satish ^a   Andreassen, Arne ^a   Simonsen, Svein ^a   Gude, Einar ^a   Dahl, Christen ^a   Skaardal, Rita ^a   Hoel, Ina ^a   Geiran, Odd ^b   Gullestad, Lars ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Allograft vasculopathy; Heart transplantation; Mortality; Renal function

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ADULT; ANGIOGRAPHY; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CAUSE OF DEATH; CONTROLLED STUDY; DIET; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HAZARD RATIO; HEART TRANSPLANTATION; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HUMANS; KIDNEY; PROGNOSIS; RISK FACTORS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 34547615540     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000268810.61393.2c     Document Type: Article

References (29)

1. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
2. Satchithananda DK, Parameshwar J, Sharples L, et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002; 21: 651-657.
3. van GT, Balk AH, Zietse R, et al. Renal insufficiency after heart transplantation: A case-control study. Nephrol Dial Transplant 1998; 13: 2322-2326.
4. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 869-879.
5. Miller LW, Pennington DG, McBride LR. Long-term effects of cyclosporine in cardiac transplantation. Transplant Proc 1990; 22: 15-20.
6. Dries DL, Exner DV, Domanski MJ, et al. The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 2000; 35: 681-689.
7. Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation 2006; 113: 671-678.
8. McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW. Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study. Circulation 2004; 109: 1004-1009.
9. Tonelli M, Wiebe N, Culleton B, et al. Chronic kidney disease and mortality risk: A systematic review. J Am Soc Nephrol 2006; 17: 2034-2047.
10. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: A multiinstitutional study of preoperative donor and recipient risk factors. Cardiac Transplant Research Database. J Heart Lung Transplant 1998; 17: 744-753.
11. Rickenbacher PR, Kemna MS, Pinto FJ, et al. Coronary artery intimal thickening in the transplanted heart. An in vivo intracoronary untrasound study of immunologic and metabolic risk factors. Transplantation 1996; 61: 46-53.
12. Valantine H, Rickenbacker P, Kemna M, et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: A prospective study. Circulation 2001; 103: 2144-2152.
13. London GM, Marchais SJ, Guerin AP, Metivier F. Impairment of arterial function in chronic renal disease: Prognostic impact and therapeutic approach. Nephrol Dial Transplant 2002; 17 Suppl 11: 13-15.
14. Campean V, Neureiter D, Varga I, et al. Atherosclerosis and vascular calcification in chronic renal failure. Kidney Blood Press Res 2005; 28: 280-289.
15. Anavekar NS, McMurray JJ, Velazquez EJ, et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 2004; 351: 1285-1295.
16. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
17. Delanaye P, Nellessen E, Grosch S, et al. Creatinine-based formulae for the estimation of glomerular filtration rate in heart transplant recipients. Clin Transplant 2006; 20: 596-603.
18. Levey AS, Coresh J, Balk E, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147.
19. Hoang K, Tan JC, Derby G, et al. Determinants of glomerular hypofiltration in aging humans. Kidney Int 2003; 64: 1417-1424.
20. Herlitz H, Lindelow B. Renal failure following cardiac transplantation. Nephrol Dial Transplant 2000; 15: 311-314.
21. Cirillo M, De Santo LS, Pollastro RM, et al. Creatinine clearance and hemoglobin concentration before and after heart transplantation. Semin Nephrol 2005; 25: 413-418.
22. Odim J, Wheat J, Laks H, et al. Peri-operative renal function and outcome after orthotopic heart transplantation. J Heart Lung Transplant 2006; 25: 162-166.
23. Kobashigawa JA, Starling RC, Mehra MR, et al. Multicenter retrospective analysis of cardiovascular risk factors affecting long-term outcome of de novo cardiac transplant recipients. J Heart Lung Transplant 2006; 25: 1063-1069.
24. London GM, Marchais SJ, Guerin AP. Arterial stiffness and function in end-stage renal disease. Adv Chronic Kidney Dis 2004; 11: 202-209.
25. Farbakhsh K, Kasiske BL. Dyslipidemias in patients who have chronic kidney disease. Med Clin North Am 2005; 89: 689-699.
26. Astor BC, Coresh J, Heiss G, et al. Kidney function and anemia as risk factors for coronary heart disease and mortality: The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006; 151: 492-500.
27. Pecoits-Filho R, Heimburger O, Barany P, et al. Associations between circulating inflammatory markers and residual renal function in CRF patients. Am J Kidney Dis 2003; 41: 1212-1218.
28. Rothenburger M, Teerling E, Bruch C, et al. Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 months' follow-up. J Heart Lung Transplant 2007; 26: 250-257.
29. Go AS, Chertow GM, Fan D, et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.NEngl J Med 2004; 351: 1296-1305.